Brazil mRNA Synthesis & Manufacturing Market (2024-2029)
The Brazil mRNA Synthesis & Manufacturing Market was valued at $16.27 Million in 2024 and projected to reach to $20.04 Million by 2029, representing a compound annual growth rate of 4.3%. Brazil's mRNA synthesis and manufacturing market is positioned for steady growth as the country prioritizes biotechnology advancement and vaccine development capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Brazil mRNA Synthesis & Manufacturing Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 4.3%, reflecting Brazil's increasing investment in biotechnology infrastructure and vaccine development capabilities.
- Brazil's market growth is driven by rising demand for mRNA-based therapeutics and the country's strategic positioning as a regional biotech hub in Latin America. The Brazilian mRNA manufacturing sector is benefiting from government initiatives to strengthen domestic pharmaceutical production and reduce dependency on imported biologics.
- Brazil's healthcare system and regulatory framework are evolving to support advanced manufacturing technologies, creating opportunities for both local and international players.
- By 2029, Brazil is expected to consolidate its role in regional mRNA production, supported by growing clinical applications and increased R&D investments in the country..
Key Market Statistics
- CAGR (2024-2029) 4.3% CAGR
- Market Size, 2024 ~USD 16.27 Million
- Forecast, 2029 ~USD 20.04 Million
- Country Brazil
Brazil mRNA Synthesis & Manufacturing Market Overview
Market Valuation :
Brazil's mRNA synthesis and manufacturing market is valued at $16.27 million in 2024, with projections reaching $20.04 million by 2029, demonstrating consistent market expansion in Latin America's largest economy.
Growth Trajectory :
The Brazilian market is growing at a CAGR of 4.3% through 2029, outpacing regional averages and reflecting increased government support for domestic biotechnology capabilities and vaccine manufacturing independence.
Biotechnology Infrastructure Investment :
Brazil is significantly expanding its biotechnology infrastructure, with increased funding for research institutions and manufacturing facilities to develop mRNA-based therapeutics and vaccines domestically.
Vaccine Development Focus :
Rising demand for mRNA-based vaccines and therapeutics is driving Brazil's market growth, supported by government initiatives to strengthen the country's pharmaceutical self-sufficiency and pandemic preparedness.
Brazil mRNA Synthesis & Manufacturing Market Dynamics
- Government initiatives promoting pharmaceutical independence and increased investment in research institutions are creating favorable conditions for market expansion.
- The 4.3% CAGR reflects Brazil's commitment to developing domestic mRNA manufacturing expertise, reducing reliance on imports, and establishing itself as a regional biotechnology hub. The Brazilian market will benefit from growing partnerships between local biotech firms and international pharmaceutical companies, coupled with rising healthcare spending and demand for innovative therapeutics.
- Regulatory framework improvements and infrastructure development will further accelerate adoption of mRNA technologies across vaccine and therapeutic applications, positioning Brazil as a key player in Latin America's biotechnology landscape..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- Brazil's mRNA synthesis market is valued at $16.27 million in 2024 and will reach $20.04 million by 2029, growing at a 4.3% CAGR.
- Brazil is positioning itself as a regional biotech leader through government-backed initiatives to develop domestic mRNA manufacturing capabilities.
- Brazil's healthcare infrastructure and regulatory environment are increasingly supportive of advanced mRNA manufacturing technologies and clinical applications.
- Brazil's market growth is underpinned by rising demand for mRNA-based therapeutics and reduced reliance on imported biologics in the country.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
Brazil mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 6.18 | 4.5 | 4.51 | 4.64 | 4.84 | 5.05 | 5.26 | 5.56 | 4.3 |
| CROS & CDMOS | 4.93 | 3.59 | 3.59 | 3.69 | 3.85 | 4.01 | 4.18 | 4.41 | 4.2 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 14.41 | 10.52 | 10.54 | 10.87 | 11.36 | 11.87 | 12.4 | 13.12 | 4.5 |
| TOTAL | 25.52 | 18.61 | 18.64 | 19.2 | 20.05 | 20.93 | 21.84 | 23.09 | 4.4 |
BRAZIL: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTIONS | 7.68 | 6.65 | 6.69 | 6.98 | 7.42 | 7.93 | 8.54 | 9.37 | 7 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 21.62 | 18.8 | 18.99 | 19.88 | 21.22 | 22.79 | 24.64 | 27.14 | 7.4 |
| SMALL-SCALE CROS & CDMOS | 2.37 | 2.03 | 2.03 | 2.09 | 2.2 | 2.34 | 2.49 | 2.71 | 6 |
| TOTAL | 31.66 | 27.48 | 27.71 | 28.95 | 30.84 | 33.06 | 35.67 | 39.22 | 7.2 |
Target Audience
- Pharmaceutical Companies : Multinational and regional pharma firms seeking to establish or expand mRNA manufacturing operations in Brazil need market data to assess feasibility, identify local partners, and optimize production strategies.
- Biotech Investors : Venture capital and private equity investors focused on Latin American biotechnology require detailed market analysis to evaluate investment opportunities and growth potential in Brazil's emerging mRNA sector.
- Government & Policy Makers : Brazilian government agencies and health authorities need market intelligence to develop biotechnology policies, allocate funding for infrastructure, and strengthen the country's vaccine manufacturing capabilities.
- Contract Manufacturing Organizations : CMOs and contract research organizations require Brazil-specific market data to identify service opportunities, assess demand for mRNA manufacturing capacity, and plan facility expansions.
- Healthcare & Research Institutions : Brazilian universities, research centers, and healthcare organizations need market insights to guide R&D investments, collaborate with industry partners, and contribute to the country's mRNA innovation ecosystem.
Reasons to Buy this Report
- Market Entry Strategy : Gain detailed insights into Brazil's mRNA market dynamics, competitive landscape, and regulatory environment to develop effective market entry strategies and identify partnership opportunities with local biotech firms.
- Investment Decision Support : Access comprehensive financial projections and growth drivers specific to Brazil's mRNA sector to make informed investment decisions in manufacturing facilities, R&D centers, and technology partnerships.
- Competitive Intelligence : Understand Brazil's unique market positioning within Latin America, identify key competitors, and assess market gaps to develop differentiated product offerings and capture market share.
- Regulatory & Policy Insights : Stay informed on Brazil's evolving regulatory framework, government incentives for biotechnology, and pharmaceutical policies that directly impact mRNA manufacturing operations and commercialization timelines.
- Growth Opportunity Assessment : Evaluate the 4.3% CAGR growth trajectory and identify high-potential segments within vaccine development, therapeutic applications, and contract manufacturing services tailored to Brazil's market needs.
Frequently asked questions
What is the current size of Brazil's mRNA synthesis and manufacturing market?
Brazil's mRNA synthesis and manufacturing market was valued at $16.27 million in 2024 and is projected to grow to $20.04 million by 2029.
What is the expected growth rate for Brazil's mRNA market through 2029?
Brazil's mRNA synthesis and manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2029.
What factors are driving growth in Brazil's mRNA manufacturing sector?
Brazil's mRNA market growth is driven by government initiatives to strengthen domestic pharmaceutical production, rising demand for mRNA-based therapeutics, and the country's strategic positioning as a regional biotech hub.
How is Brazil's regulatory environment supporting mRNA manufacturing?
Brazil's healthcare system and regulatory framework are evolving to support advanced manufacturing technologies, creating a more favorable environment for mRNA production and clinical applications in the country.
What role will Brazil play in Latin America's mRNA market by 2029?
By 2029, Brazil is expected to consolidate its position as a regional mRNA production leader in Latin America, supported by growing clinical applications and increased R&D investments.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
